Actionnariat et activité des initiés pour Lifecore Biomedical, Inc. (LFCR): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $4.16 |
| Capitalisation | $156M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-04 | Kiper Christopher S | A-Award | 25,907 | |
| 2026-06-04 | OBUS NELSON | A-Award | 25,907 | |
| 2026-06-04 | Aryeh Jason | A-Award | 25,907 | |
| 2026-06-04 | Schechter Joshua | A-Award | 25,907 | |
| 2026-06-04 | Korenberg Matthew E | A-Award | 25,907 | |
| 2026-06-04 | Antunes Humberto Calheiros | A-Award | 25,907 | |
| 2026-06-04 | Johnson Paul Harold | A-Award | 25,907 | |
| 2026-06-04 | HOUDE LOVAS KATRINA | A-Award | 25,907 | |
| 2026-05-20 | Josephs Paul | F-InKind | 40,413 | $185K |
| 2026-04-14 | Salus Thomas D. | F-InKind | 24,645 | $128K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $5.4M | $2.9M | $1.1M | $360000 | $1.2M | $991000 | $19.1M | $8.5M | $8.3M | $17.5M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $45.9M | $53.9M | $69.6M | $76.2M | $41.4M | $38.3M | $29.0M | $31.2M | $43.7M | $33.8M |
| Stocks | $25.3M | $31.8M | $54.1M | $66.3M | $63.1M | $36.0M | $40.8M | $40.0M | $32.3M | $29.1M |
| Actifs Courants | $81.3M | $97.1M | $133.0M | $157.1M | $148.3M | $116.7M | $93.9M | $81.0M | $85.7M | $82.3M |
| Immobilisations Corporelles | $133.2M | $159.6M | $200.0M | $217.7M | $137.4M | $124.2M | $138.7M | $149.2M | $129.0M | $127.3M |
| Goodwill | $54.8M | $54.5M | $76.7M | $69.4M | $33.9M | $13.9M | $13.9M | $13.9M | $13.9M | $13.9M |
| Actifs Incorporels | $22.8M | $21.8M | $45.2M | $38.1M | $25.6M | $4.2M | $4.2M | $4.2M | $4.2M | 0 |
| Actifs Totaux | $358.0M | $404.7M | $519.1M | $541.3M | $502.9M | $274.7M | $253.5M | $254.0M | $239.3M | $232.2M |
| Dettes Fournisseurs | $24.5M | $34.7M | $54.0M | $51.6M | $16.3M | $13.0M | $22.1M | $16.3M | $8.2M | $5.8M |
| Dette à Court Terme | $7.9M | $31.9M | $61.8M | $89.0M | $29.0M | $138.2M | $580000 | $943000 | $3.4M | $773000 |
| Passifs Courants | $51.5M | $88.4M | $137.1M | $164.4M | $101.9M | $176.6M | $39.3M | $38.9M | $30.2M | $23.6M |
| Dette à Long Terme | $42.3M | $37.4M | $87.7M | $101.4M | $164.9M | $97.6M | $101.1M | $123.7M | $127.0M | $135.6M |
| Passifs Totaux | $129.9M | $152.1M | $248.9M | $310.3M | $300.1M | $186.9M | $257.8M | $242.6M | $238.0M | $246.4M |
| Réserves | $84.5M | $109.3M | $109.7M | $71.2M | $38.6M | -$79.0M | -$178.5M | -$166.5M | -$205.2M | -$223.2M |
| Capitaux Propres | $226.6M | $252.6M | $270.1M | $231.0M | $202.8M | $87.8M | -$4.2M | $11.3M | $1.3M | -$14.2M |
| Dette Totale | $54.0M | $72.9M | $152.5M | $221.1M | $215.9M | $247.8M | $112.6M | $133.6M | $130.8M | $142.6M |
| Dette Nette | $48.6M | $70.0M | $151.4M | $220.8M | $214.7M | $246.8M | $93.5M | $125.1M | $122.6M | $125.1M |
| Fonds de Roulement | $29.8M | $8.7M | -$4.0M | -$7.3M | $46.4M | -$59.9M | $54.6M | $42.2M | $55.5M | $58.7M |
Santé financière
| Dette / Capitaux propres | 9.64 |
| Ratio de liquidité | 3.87 |
Rentabilité
| Rentabilité des capitaux propres | -376.95% |
| Rentabilité du capital investi | -1.25% |
| Rentabilité des actifs | -16.25% |
| Marge brute | 29.68% |
| Marge opérationnelle | -2.12% |
| Marge nette | -30.40% |
Entreprises liées: ACB · ACHV · BIOA · CGC · CVRX · IMMP · OMI
Explorer le secteur: Healthcare · Drug Manufacturers - Specialty & Generic
Plus de sections de LFCR: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions